Table 2.
Authors | Study Period | No. of Centers | No. of Cases | Technical Success, % | Procedural Success, % | Overall MACE, % | Death, % | Acute MI, % | Stroke, % | TVR, % | Pericardial Tamponade, % |
---|---|---|---|---|---|---|---|---|---|---|---|
Dedicated CTO PCI registries | |||||||||||
Christopoulos et al25 | 2012–2015 | 11 | 1036 | 91 | 90 | 1.7 | 0.3 | 0.7 | 0.1 | 0.2 | 0.5 |
Habara et al26 | 2012–2013 | 56 | 3229 | ··· | 88 | 0.5 | 0.2 | 0.1 | 0.1 | 0.0 | 0.3 |
Wilson et al27 | 2012–2014 | 7 | 1156 | 90 | ··· | 1.6 | 0 | 0.8 | 0.4 | 0.0 | 0.7 |
Maeremans et al28 | 2014–2015 | 17 | 1253 | 89 | 86 | 2.6 | 0.2 | 0.2 | 2.2 | 0.1 | 1.3 |
Sapontis et al8 | 2013–2017 | 12 | 1000 | 86 | 85 | 7.0 | 0.9 | 2.6 | 0.0 | 0.1 | ···a |
CTO PCI analyses from all‐comer PCI registries | |||||||||||
Brilakis et al30 | 2009–2013 | ··· | 22365 | ··· | 59 | 1.6 | 0.4 | 1.9 | 0.1 | 0.4 | 0.1 |
Hannan et al29 | 2009–2012 | 61 | 4030 | ··· | 61.3 | 1.1 | ··· | ··· | ··· | ··· | ··· |
Ramunddal et al32 | 2005–2012 | ··· | 6442 | ··· | 54.2 | ··· | ··· | ··· | ··· | ··· | ··· |
Tsai et al31 | 2007–2013 | 79 | 2394 | 79.8 | 79.7 | 4.3 | 0.0 | 0.13 | 0.0 | 0.0 | 0.0 |
CTO indicates chronic total occlusion; MACE, major adverse cardiovascular event; MI, myocardial infarction; PCI, percutaneous coronary intervention; and TVR, target vessel revascularization.
The incidence of tamponade was not reported.